Aadi Bioscience Corporate Overview 2021 | Investor Presentation

Aadi Bioscience Inc. is a biopharmaceutical company focused on developing and commercializing innovative product candidates, including FYARRO (nab-sirolimus, ABI-009). This June 2021 corporate overview presents Aadi's business strategy, clinical development programs, and proposed merger with Aerpio. The presentation outlines the company's research pipeline and commercial prospects in oncology and related therapeutic areas.